Huntington’s gene therapy research has reached a turning point, expert says
An expert involved in the first successful gene therapy trial for Huntington's Disease discusses the trial results and challenges with the FDA.
GSK prepared for potential expansion of meningitis vaccine schedule amid UK outbreak
Navigating the valley of death: a how-to from an investor’s perspective
FDA issues CRL to Aldeyra’s reproxalap drug application
Transient but transformative: Sanofi’s mRNA CAR-T enters in vivo race
RFK Jr’s vaccine overhaul halted by federal judge’s ruling
Analysis
View More
Themes
View MoreCinnaGen Enters EU Market with EMA Approval for Zandoriah®
CinnaGen today announced that the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of Zandoriah® (teriparatide),…
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer
Huawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential
First responders see AI and other advanced tech as essential
What does the EU Data Act mean for businesses?